Merit Medical Systems, Inc. (MMSI)

Market Cap	4.23B -31.8%
Revenue (ttm)	1.52B +11.8%
Net Income	128.49M +6.8%
EPS	2.13 +4.9%
Shares Out	59.65M
PE Ratio	33.30
Forward PE	17.57
Dividend	n/a
Ex-Dividend Date	n/a

Volume	470,299
Open	70.83
Previous Close	70.10
Day's Range	70.33 - 71.91
52-Week Range	66.34 - 100.19
Beta	0.64
Analysts	Strong Buy
Price Target	99.13 (+39.76%)
Earnings Date	Apr 30, 2026

About MMSI

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology produc...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Aug 9, 1990
• Employees: 7,500
• Stock Exchange: NASDAQ
• Ticker Symbol: MMSI
• Website: https://www.merit.com

Financial Performance

In 2025, Merit Medical Systems's revenue was $1.52 billion, an increase of 11.75% compared to the previous year's $1.36 billion. Earnings were $128.49 million, an increase of 6.76%.

Analyst Summary

According to 8 analysts, the average rating for MMSI stock is "Strong Buy." The 12-month stock price target is $99.13, which is an increase of 39.76% from the latest price.

Price Target

$99.13

(39.76% upside)

Analyst Consensus: Strong Buy